Why Did AMD Stock Go Up?
Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…
Sell
43
BHVN Quote, Financials, Valuation and Earnings
Last price:
$13.47
Seasonality move
:
-30.1%
Day range:
$13.26 - $14.01
52-week range:
$7.48 - $44.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.70x
Volume:
1.8M
Avg. volume:
3.4M
1-year change:
-66.81%
Market cap:
$1.8B
Revenue:
--
EPS (TTM):
-$7.60
Analysts' Opinion
-
Consensus RatingBiohaven Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $20.80, Biohaven Ltd. has an estimated upside of 53.96% from its current price of $13.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 100% downside risk from its current price of $13.51.
Fair Value
-
According to the consensus of 13 analysts, Biohaven Ltd. has 53.96% upside to fair value with a price target of $20.80 per share.
BHVN vs. S&P 500
-
Over the past 5 trading days, Biohaven Ltd. has overperformed the S&P 500 by 13.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Biohaven Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Biohaven Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Biohaven Ltd. reported revenues of --.
Earnings Growth
-
Biohaven Ltd. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Biohaven Ltd. reported earnings per share of -$1.64.
Enterprise value:
1.8B
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.84x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$4.2M
Return On Assets:
-153.32%
Net Income Margin (TTM):
--
Return On Equity:
-349.4%
Return On Invested Capital:
-213.94%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$2.8M | -$3.9M | -$4.2M | -$1M | -$1.1M | |
| Operating Income | -$495.8M | -$848.9M | -$792.6M | -$178.2M | -$169.4M | |
| EBITDA | -$493M | -$845M | -$788.4M | -$177.2M | -$168.3M | |
| Diluted EPS | -$6.81 | -$9.35 | -$7.60 | -$1.70 | -$1.64 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $80.6M | $310.6M | $440.5M | $323.6M | |
| Total Assets | -- | $135.6M | $382.7M | $510.5M | $409.1M | |
| Current Liabilities | -- | $28.4M | $62.2M | $152.3M | $113M | |
| Total Liabilities | -- | $35.4M | $92.7M | $194.5M | $426.3M | |
| Total Equity | -- | $100.2M | $290M | $316M | -$17.2M | |
| Total Debt | -- | $4.1M | $28.3M | $25.3M | $308.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$292.3M | -$526.6M | -$649.5M | -$141.3M | -$145.7M | |
| Cash From Investing | -$130.3M | -$161.2M | $226.6M | -$93.4M | $165M | |
| Cash From Financing | $532M | $615M | $523.2M | $80.4M | $122K | |
| Free Cash Flow | -$295.1M | -$531.1M | -$650.3M | -$141.9M | -$145.7M | |
BHVN
Sector
Market Cap
$1.8B
$25.9M
Price % of 52-Week High
30.51%
51.6%
Dividend Yield
0%
0%
Shareholder Yield
-20.73%
-1.66%
1-Year Price Total Return
-66.81%
-18.99%
Beta (5-Year)
--
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$12.57
200-day SMA
Sell
Level
$14.52
Bollinger Bands (100)
Buy
Level
9.87 - 15.69
Chaikin Money Flow
Buy
Level
8.7M
20-day SMA
Buy
Level
$11.67
Relative Strength Index (RSI14)
Buy
Level
62.54
ADX Line
Buy
Level
18.21
Williams %R
Sell
Level
-10.6019
50-day SMA
Buy
Level
$10.58
MACD (12, 26)
Buy
Level
0.63
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
39.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.773)
Sell
CA Score
(Annual)
Level (-6.3697)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (10.1381)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Stock Forecast FAQ
In the current month, BHVN has received 8 Buy ratings 5 Hold ratings, and 0 Sell ratings. The BHVN average analyst price target in the past 3 months is $20.80.
-
Where Will Biohaven Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Biohaven Ltd. share price will rise to $20.80 per share over the next 12 months.
-
What Do Analysts Say About Biohaven Ltd.?
Analysts are divided on their view about Biohaven Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Biohaven Ltd. is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is Biohaven Ltd.'s Price Target?
The price target for Biohaven Ltd. over the next 1-year time period is forecast to be $20.80 according to 13 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is BHVN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Biohaven Ltd. is a Buy. 8 of 13 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BHVN?
You can purchase shares of Biohaven Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Biohaven Ltd. shares.
-
What Is The Biohaven Ltd. Share Price Today?
Biohaven Ltd. was last trading at $13.47 per share. This represents the most recent stock quote for Biohaven Ltd.. Yesterday, Biohaven Ltd. closed at $13.51 per share.
-
How To Buy Biohaven Ltd. Stock Online?
In order to purchase Biohaven Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BHVN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BHVN
Sector
P/E ratio
--
23.82x
PEG ratio
--
-0.01x
P/B ratio
6.70x
1.83x
Price / LTM sales
--
1.56x
Growth Metrics
BHVN
Sector
Revenue growth
--
4.18%
Earnings growth
3.5%
9.66%
Revenue (5-year growth)
--
6.28%
Earnings forecast
-$0.87
-$0.18
Profitability
BHVN
Sector
Profitability FY 2024
-$3.9M
$3.1M
Return on invested capital
-213.94%
-32.89%
Return on assets
-153.32%
-29.56%
Return on equity
-349.4%
-38.66%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Feb
9
Balance Sheet
BHVN
Sector
Total cash
$260.8M
$25.2M
Short term investments
$386.9M
$25.1M
Total assets
$615.1M
$73M
Long term debt
$308.7M
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Data Centers Be In Space?
With demand for data centers seemingly growing by the day,…
Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
47
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
56
INTC alert for Jan 24
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
64
BNR alert for Jan 24
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Sell
19
APGE alert for Jan 24
Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
